Citation only via OpenAlex

Targeting inflammaging in Alzheimer’s disease: molecular pathways and emerging pharmacotherapies

Modhi Obaidan Alotaibi, Hayder M. Al‐kuraishy, Esraa Hammadi Fahad, Ahmed M Abdelaziz, Gaber El‐Saber Batiha

Inflammopharmacology · 2026 · ▲ 3 citations

Chronic inflammation

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1007/s10787-026-02281-8
Canonical: link ↗
Fetched: 2026-10-29 MST

Cite this

APA

Alotaibi, M.O., Al‐kuraishy, H.M., Fahad, E.H., Abdelaziz, A.M., & Batiha, G.E. (2026). Targeting inflammaging in Alzheimer’s disease: molecular pathways and emerging pharmacotherapies. <em>Inflammopharmacology</em>. https://doi.org/10.1007/s10787-026-02281-8

Vancouver

Alotaibi MO, Al‐kuraishy HM, Fahad EH, Abdelaziz AM, Batiha GE. Targeting inflammaging in Alzheimer’s disease: molecular pathways and emerging pharmacotherapies. Inflammopharmacology. 2026. doi:10.1007/s10787-026-02281-8.

BibTeX

@article{modhi2026Target, title = {Targeting inflammaging in Alzheimer’s disease: molecular pathways and emerging pharmacotherapies}, author = {Modhi Obaidan Alotaibi and Hayder M. Al‐kuraishy and Esraa Hammadi Fahad and Ahmed M Abdelaziz and Gaber El‐Saber Batiha}, journal = {Inflammopharmacology}, year = {2026}, doi = {10.1007/s10787-026-02281-8}, }